CymitQuimica logo

CAS 1624602-30-7

:

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
10 produits concernés.
  • Quinoline, 7-chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]-

    CAS :
    Formule :C19H16ClN5O6S
    Degré de pureté :99%
    Couleur et forme :Solid
    Masse moléculaire :477.8782

    Ref: IN-DA001T5R

    10mg
    96,00€
    25mg
    150,00€
  • VR23

    CAS :
    VR23
    Degré de pureté :98%
    Masse moléculaire :477.88g/mol

    Ref: 54-OR1023366

    100mg
    280,00€
  • VR23

    CAS :
    VR23
    Degré de pureté :≥98%
    Masse moléculaire :477.88g/mol

    Ref: 54-BUP11062

    10mg
    50,00€
    25mg
    94,00€
    50mg
    164,00€
    100mg
    261,00€
    200mg
    361,00€
  • VR23

    CAS :
    <p>VR23: Potent proteasome inhibitor; IC50: 1 nM trypsin, 50-100 nM chymotrypsin, 3 μM caspase-like.</p>
    Formule :C19H16ClN5O6S
    Degré de pureté :98.99% - 99.22%
    Couleur et forme :Solid
    Masse moléculaire :477.88
  • Ref: 7W-GW0993

    1mg
    93,00€
    5mg
    214,00€
    25mg
    582,00€
  • Quinoline, 7-chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]-

    CAS :
    Degré de pureté :99%
    Masse moléculaire :477.8800049

    Ref: 10-F865719

    10mg
    82,00€
  • 4-((4-(7-Chloroquinolin-4-yl)piperazin-1-yl)sulfonyl)-3-nitroaniline

    Produit contrôlé
    CAS :
    <p>Applications 4-((4-(7-Chloroquinolin-4-yl)piperazin-1-yl)sulfonyl)-3-nitroaniline is a VR23 (V767023) related compound. VR23 is a quinoline-sulfonyl hybrid proteasome inhibitor which is used in cancer therapeutics. Targets cancer via cycline E-mediated centrosome.<br>References Pundir, S. et al.: Canc. Res., 75, 4164 (2015);<br></p>
    Formule :C19H18ClN5O4S
    Couleur et forme :Neat
    Masse moléculaire :447.9

    Ref: TR-C430340

    5mg
    188,00€
    25mg
    794,00€
    50mg
    1.371,00€
  • 7-Chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]quinoline-d8

    Produit contrôlé
    CAS :
    <p>Applications 7-Chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]quinoline-d8 is a Quinoline-Sulfonyl Hybrid Proteasome Inhibitor used to treat cancer.<br>References Pundir, S., et al.: Cancer Research, 75, 4164 (2015);<br></p>
    Formule :C19H8D8ClN5O6S
    Couleur et forme :Neat
    Masse moléculaire :485.93

    Ref: TR-C377562

    10mg
    895,00€
    25mg
    1.964,00€
    2500µg
    304,00€
  • 4-((4-(7-Chloroquinolin-4-yl)piperazin-1-yl)sulfonyl)benzene-1,3-diamine

    Produit contrôlé
    CAS :
    Formule :C19H20ClN5O2S
    Couleur et forme :Neat
    Masse moléculaire :417.912

    Ref: TR-C430345

    250mg
    8.684,00€
  • 7-Chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]quinoline-d8

    CAS :
    <p>7-Chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]quinoline-d8 is a compound with unique characteristics that make it suitable for various applications. It is a 3beta-hydroxy steroid additive that offers stability and UV resistance. The amino group in this compound allows for stabilization and catalytic hydrogenation, making it useful in synthesis processes. Additionally, the presence of hydroxy and carbonyl groups enables hydrogen bonding and enhances its catalytic properties. With its diverse range of features, 7-Chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]quinoline-d8 is an excellent choice for industries seeking a reliable and efficient compound for their specific needs.</p>
    Formule :C19H8D8ClN5O6S
    Degré de pureté :Min. 95%
    Masse moléculaire :485.93 g/mol

    Ref: 3D-ZPC60230

    50mg
    743,00€
    500mg
    2.165,00€